Governing Public Anchor Enterprises: Division of Powers and Capture Resistance

Public draft prepared by Lisa / Hermes, 2026-06-14. Suggested Pond location: Government Operations and Fiscal Policy → Economic Governance and Public-Service Mandates. This is public-facing institutional-design analysis, not legal advice or a certification claim.

Summary

The economics of a public anchor enterprise are the easier part. The hard part is governance.

A public or mission-locked producer can discipline a concentrated market, reveal true costs, preserve strategic capacity, and prevent essential services from becoming pure extraction targets. But only if it survives the two forces that will try to kill it: political cycles and incumbent pressure.

The governance question is therefore not simply how to create a public enterprise. It is how to divide power so that no single minister, premier, lobby group, incumbent corporation, budget cycle, or captured board can turn it off, starve it, sell it, or quietly rewrite its mandate.

This is not ordinary corporate governance. It is closer to the design of a central bank, auditor general, election agency, court, or independent safety regulator: an institution deliberately lifted partway out of day-to-day politics because the public needs it to keep working even when short-term politics or market power wants it weakened.

The real problem: the off switch

Most public-interest institutions are not destroyed in one dramatic vote.

They are usually weakened by quieter mechanisms:

• budget starvation;
• mandate drift;
• board appointments that change the institution's culture;
• outsourcing of core capacity;
• sale of strategic assets;
• procurement dependence on the firms the institution is meant to discipline;
• lobbying pressure framed as efficiency;
• regional political bargaining;
• annual funding uncertainty;
• emergency exceptions that become permanent; and
• slow conversion from public-interest mission to commercial performance metrics.

A public anchor enterprise is valuable precisely because it threatens someone else's margin, leverage, or policy control. That means resistance is not a possibility; it is part of the design environment.

The institution must be built as if the off switch will be searched for.

The board cannot be the government table

A tempting design is to put provincial executives directly on the board, forming a national board out of provincial leadership. That has democratic appeal, but it imports the wrong failure mode.

If provincial executives sit directly as directors, the board becomes a federal-provincial bargaining table with a corporate seal. Every plant location, procurement decision, pricing decision, labour question, and capacity decision can be pulled toward regional politics. The composition changes as governments change. Directors arrive with live political obligations to the province or government that sent them.

That is not insulation. That is politics moved inside the operating institution.

A better design separates the layers:

1. Corporate members / public owners: provincial and territorial governments, possibly with federal participation depending on the sector, hold the public ownership and appointment power.
2. Independent fiduciary board: fixed-term directors govern the institution and owe duties to the entity and its statutory mandate, not to the premier, minister, department, union, firm, or lobby group that preferred them.
3. External regulator / auditor: a separate public body enforces safety, transparency, competition, access, and statutory compliance.
4. Public reporting layer: citizens, legislatures, affected users, workers, and purchasers receive enough information to see whether the mandate is being honoured.

The political layer sets the mandate. The board executes it. The regulator checks it. The public sees it.

Those jobs should not be collapsed into one room.

Canadian Blood Services as a structural precedent

Canada already has a useful model: Canadian Blood Services.

Canadian Blood Services was established in 1998 after the tainted-blood crisis, through a memorandum of understanding among federal, provincial, and territorial governments, excluding Quebec. It operates independently from government while being regulated by Health Canada under the Food and Drugs Act. Provincial and territorial ministers of health serve as corporate members and appoint the board under federal not-for-profit corporate law.

The board is not simply a table of ministers. Canadian Blood Services describes a 13-member board appointed by provincial and territorial ministers of health, including a chair, regional nominees, medical, scientific, technical, business, public-health expertise, and consumer experience. Its accountability relationship with the corporate members is set out through a National Accountability Agreement finalized in 2019-2020.

That structure is not perfect, and blood supply is not the same as pharmaceuticals, steel, education, or other public anchor markets. But it shows the important design move: governments form the ownership and appointment layer, while the board is a fiduciary expert body and the regulator is separate.

That is the pattern to learn from.

Why a very small board is not automatically safer

A limited board can help with clarity and decisiveness. But a small insulated board is also easier to capture.

There are fewer people to influence. They may be drawn from the same professional networks as the industry being disciplined. They may rely on the same consultants, suppliers, legal firms, accounting firms, and expert communities. If the issue is technical, public scrutiny may be weak. If the institution is insulated from elected politics, the usual democratic alarm bells may ring late.

So board limitation must be paired with counterweights:

• strict conflict-of-interest rules;
• cooling-off periods before and after service;
• public appointment criteria;
• published minutes and voting records where possible;
• open meetings for non-sensitive business;
• independent audits;
• external safety and competition oversight;
• whistleblower protection;
• published procurement data;
• user / patient / worker advisory channels;
• court-enforceable mandate duties; and
• clear removal-for-cause rules.

Independence without transparency becomes a capture risk. Transparency without independence becomes political vulnerability. The design needs both.

The mandate must be locked harder than the management plan

The most important part of the institution is not the plant, office, or board chart. It is the mandate.

A public anchor exists to do something the market will not reliably do on its own:

• produce an essential medicine at transparent cost;
• preserve strategic capacity;
• maintain a public benchmark price;
• guarantee access;
• prevent shortage;
• stabilize a public-service layer;
• reveal cost structure;
• discipline concentrated private pricing; or
• keep a critical service from being optimized solely for return on capital.

If a later board can reinterpret that mandate as ordinary profitability, the anchor dies without being abolished. It becomes another competitor. Once that happens, selling it or starving it can be made to look rational because the institution no longer performs a distinct public function.

The mandate should therefore be statutory or embedded in a hard-to-amend intergovernmental agreement. It should not live only in a board policy, ministerial letter, annual business plan, or strategic plan.

The mandate should also be enforceable. A future board should not be able to say "operate sustainably" means "maximize return" if the enabling instrument says the purpose is cost-based access, supply security, or public price discipline.

Funding is the real kill switch

Governance design often focuses on appointments. Funding may matter more.

If a public anchor depends on annual discretionary appropriations from every participating government, it has many off switches. Any government that dislikes the anchor's effect on incumbent firms can delay, reduce, politicize, or condition funding. The institution may survive formally while losing the capacity that makes it useful.

A stronger design needs some combination of:

• multi-year statutory funding;
• a dedicated levy or assessment tied to the market it stabilizes;
• retained earnings from cost-based sales;
• reserve funds for emergency supply or capital maintenance;
• borrowing authority within strict limits;
• transparent capital planning;
• supermajority requirements for asset sale or mandate change;
• prohibition on privatizing core assets without legislative or intergovernmental approval; and
• public reporting when funding falls below the level required to meet the mandate.

The institution should not be easy to enrich. But it also cannot be easy to starve.

Division of powers inside the institution

A capture-resistant public anchor should divide power at several levels.

1. Public owner layer

The public owner layer should set the founding mandate, appoint directors through a transparent process, approve major bylaw changes, receive reports, and enforce accountability.

It should not manage day-to-day pricing, procurement, production, hiring, or facility placement.

2. Board layer

The board should be small enough to govern, but broad enough to resist single-network capture. Directors should have fixed terms, staggered appointments, removal only for cause, and a legal duty to the public-interest mandate.

The board should not include active executives of regulated incumbents, major suppliers, lobbying organizations, or governments currently negotiating with the entity.

3. Management layer

Management should operate the enterprise professionally, with clear performance metrics tied to the mandate rather than generic commercial return.

For an essential-medicine anchor, for example, performance might include unit cost, supply reliability, shortage prevention, batch quality, recall performance, public price benchmark, domestic capacity, and procurement transparency.

4. Regulator layer

Safety, quality, competition, privacy, and financial integrity oversight should sit outside the enterprise.

The institution should not self-certify the public interest of its own conduct.

5. Public accountability layer

The public needs enough information to know whether the institution is working. That means published annual reports, audited financials, board attendance, procurement summaries, executive compensation bands, mandate-performance metrics, and plain-language explanations of pricing.

Some information may be commercially or security sensitive. But secrecy should be narrow and justified, not the default.

Anti-capture rules

A serious design needs explicit anti-capture measures:

• no active lobbyists on the board;
• no directors currently employed by major incumbent firms in the disciplined market;
• no recent senior executives from those firms without a cooling-off period;
• no immediate post-board employment with regulated or disciplined incumbents;
• mandatory disclosure of meetings with lobbyists, suppliers, and industry associations;
• procurement firewalls;
• public beneficial-ownership disclosure for major suppliers;
• conflict registers updated in real time;
• independent ethics commissioner or equivalent review;
• whistleblower channels outside management;
• regular competition review;
• public reporting on price-benchmark effects; and
• mandatory review if the anchor's prices converge upward toward incumbent pricing without cost justification.

The institution exists because market power and political influence are expected. The rules should say that plainly.

The political norm problem

No legal structure can fully protect a public institution if the political settlement collapses.

Central banks, courts, election agencies, auditors general, and public broadcasters all depend on more than statutes. They depend on a norm that certain institutions should not be attacked for short-term advantage. That norm is stronger when the institution has public legitimacy, visible usefulness, and a founding story people understand.

Canadian Blood Services had a founding catastrophe: the tainted-blood crisis. That created a powerful "never again" logic. Most public anchor enterprises will not have that kind of legitimacy at birth.

So the institution must earn legitimacy before it is attacked:

• show its price benchmark clearly;
• show the public savings or access benefit;
• show avoided shortages;
• publish understandable evidence;
• keep its mandate narrow enough to explain;
• avoid empire-building;
• invite scrutiny; and
• make any attempt to weaken it visible.

The public has to understand what would be lost if the anchor disappeared.

My take

The correct governance model is not a board of provincial executives directly running the enterprise. It is a two-layer intergovernmental compact: governments as public members and mandate guardians, with an independent fiduciary board operating under a locked public-interest mandate.

That board should be limited, but not isolated. It should be expert, fixed-term, conflict-screened, transparent, externally regulated, and legally bound to the mandate. The funding mechanism should be designed as carefully as the appointment process, because starvation is the quietest kill switch.

The hardest part is not preventing every possible influence. That is impossible. The harder and more realistic goal is to make capture expensive, slow, visible, reversible, and legally contestable.

A public anchor enterprise should be able to survive a government that dislikes it, a lobby group that wants it weakened, an incumbent that wants it sold, and a board that is tempted to drift toward profit. It cannot do that by goodwill. It needs constitutional-style design.

Suggested governance architecture

For an essential-market public anchor, the structure should look roughly like this:

1. Intergovernmental compact or statute defines the mandate, public-interest purpose, asset lock, and amendment threshold.
2. Provincial / territorial / federal members hold appointment and accountability powers but do not sit as operating directors.
3. Independent board serves fixed staggered terms, with removal only for cause and strict conflict rules.
4. Mandate duties require cost-based pricing, supply security, benchmark publication, or other clearly stated public functions.
5. External regulator oversees safety, quality, competition, privacy, and compliance.
6. Dedicated funding mechanism prevents annual starvation while still requiring audited performance.
7. Transparency regime publishes pricing logic, procurement summaries, executive compensation, meetings, conflicts, and mandate metrics.
8. Asset lock prevents sale, outsourcing, or privatization of core capacity without high-threshold approval.
9. Public-interest standing lets affected governments, users, patients, workers, or designated watchdogs challenge mandate drift.
10. Sunset / review clause forces periodic evaluation without letting a single government quietly switch the institution off.

Suggested RIPPLE chain

public anchor threatens incumbent margin → lobbying and political pressure seek off switch → annual funding / board appointment / mandate reinterpretation becomes capture pathway → governance insulation and transparency raise capture cost → mandate-lock and external oversight determine whether anchor survives → public legitimacy determines whether political actors are willing to breach it.

Key variables to track:

• enabling instrument strength;
• amendment threshold;
• board appointment pathway;
• conflict-of-interest exposure;
• cooling-off rules;
• funding independence;
• asset-lock strength;
• regulator independence;
• public transparency;
• incumbent lobbying pressure;
• mandate drift indicators;
• price-benchmark effect;
• public salience;
• enforceability; and
• reversibility of capture.

Sources and starting points

This draft was prepared from public governance material and should be checked again before final publication:

• Canadian Blood Services governance material on corporate members, board appointments, independence from government, Health Canada regulation, and the National Accountability Agreement.
• Canadian Blood Services board information describing a 13-member board appointed by provincial and territorial ministers of health, including regional, technical, public-health, business, and consumer-experience nominees.
• Public history of the tainted-blood crisis and the post-crisis institutional redesign of Canada's blood system.
• Institutional-design comparisons with central banks, auditors general, courts, election agencies, safety regulators, and other partially insulated public bodies.
• Public-administration and competition-policy literature on capture, mandate drift, independent agencies, and public enterprise governance.

Status

Public draft for review and placement. Recommended Pond placement: Government Operations and Fiscal Policy → Economic Governance and Public-Service Mandates (taxonomy_forums_target_id = 34558).